Please use this identifier to cite or link to this item: https://hdl.handle.net/11147/7759
Title: Chitosan/montmorillonite composite nanospheres for sustained antibiotic delivery at post-implantation bone infection treatment
Authors: Kımna, Ceren
Değer, Sibel
Tamburacı, Sedef
Tıhmınlıoğlu, Funda
Kımna, Ceren
Değer, Sibel
Tamburacı, Sedef
Tıhmınlıoğlu, Funda
Izmir Institute of Technology. Chemical Engineering
Keywords: Drug delivery
Antibiotics
Bone
Nanocomposites
Infection
Issue Date: May-2019
Publisher: IOP Publishing Ltd.
Source: Kımna, C., Değer, S., Tamburacı, S., and Tıhmınlıoğlu, F. (2019). Chitosan/montmorillonite composite nanospheres for sustained antibiotic delivery at post-implantation bone infection treatment. Biomedical Materials, 14(4). doi:10.1088/1748-605X/ab1a04
Abstract: Despite the advancements in bone transplantation operations, inflammation is still a serious problem that threatens human health at the post-implantation period. Conventional antibiotic therapy methods may lead to some side effects such as ototoxicity and nephrotoxicity, especially when applied in high doses. Therefore, local drug delivery systems play a vital role in bone disorders due to the elimination of the disadvantages introduced by conventional methods. In the presented study, it was aimed to develop Vancomycin (VC) and Gentamicin (GC) loaded chitosan-montmorillonite nanoclay composites (CS/MMT) to provide required antibiotic doses to combat post-implantation infection. CS/MMT nanocomposite formation was supplied by microfluidizer homogenization and spherical drug carrier nanoparticles were obtained by electrospraying technique. Three factors; voltage, distance and flowrate were varied to fabricate spherical nanoparticles with uniform size. Emprical model was developed to predict nanosphere size by altering process variables. Nanospheres were characterized in terms of morphology, hydrodynamic size, zeta potential, drug encapsulation efficiency and release profile. Drug loaded nanospheres have been successfully produced with a size range of 180-350 nm. Nanocomposite drug carriers showed high encapsulation efficiency (80%-95%) and prolonged release period when compared to bare chitosan nanospheres. The drug release from nanocomposite carriers was monitored by diffusion mechanism up to 30 d. The in vitro release medium of nanospheres showed strong antimicrobial activity against gram-positive S. aureus and gram-negative E. coli bacteria. Furthermore, it was found that the nanospheres did not show any cytotoxic effect to fibroblast (NIH/3T3) and osteoblast (SaOS-2) cell lines. The results demonstrated that the prepared composite nanospheres can be a promising option for bone infection prevention at the post implantation period.
URI: https://doi.org/10.1088/1748-605X/ab1a04
https://hdl.handle.net/11147/7759
ISSN: 1748-6041
1748-6041
Appears in Collections:Chemical Engineering / Kimya Mühendisliği
PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Sürdürülebilir Yeşil Kampüs Koleksiyonu / Sustainable Green Campus Collection
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

Files in This Item:
File Description SizeFormat 
kimna2019.pdfMakale (Article)2.43 MBAdobe PDFThumbnail
View/Open
Show full item record

CORE Recommender

SCOPUSTM   
Citations

3
checked on Jun 12, 2021

WEB OF SCIENCETM
Citations

5
checked on Jun 12, 2021

Download(s)

2
checked on Jun 17, 2021

Google ScholarTM

Check

Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.